Third Opinion on Prostate Cancer


Book Description

Hospitals and private clinics who rely on pathology reports must take responsibility for their negligence and disclose the third party mistakes that have caused their patients a lifetime of suffering. This book will convince you to take the extra time to get more than one opinion about your cancer diagnosis.This book is packed with research, interviews, and statistics related to prostate cancer. It describes how the author endured the false alarm of being misdiagnosed with Gleason 8 prostate cancer by four different pathologists and two different laboratories. This book is a must-read for anyone who is concerned about or who has been diagnosed with prostate cancer. Even if you are in the middle of any type of treatment, this book will increase your awareness about lifesaving issues. It will be your crash course on everything you need to know about prostate health and equip you with the knowledge you need to communicate effectively with your urologist and pathologist.




3rd Opinion on Prostate Cancer


Book Description

The minute that your urologist tells you that your biopsy is positive for prostate cancer, don't panic. I have been there and that is why this book is written. Here are ten facts: 1. Identifying cancerous cells in a biopsy of prostate gland is more difficult than identifying any other cancerous cells in biopsies of any other organs. 2. Laboratories often make mistakes, especially the laboratory that determined I had prostate cancer when I really did not. 3. Elevated PSA and MRI scanning is not accurate to determine prostate cancer, especially if you have an infection that elevates PSA. 4. If you ask your physician that you need to get a second opinion, s/he would refer you to urologists in his/her circle, locally. More than likely, the second opinion will confirm the first opinion of the primary physician. 5. In any surgery, especially prostate cancer surgery, you need to get additional two opinions, and the third one must be out of the state that you reside. 6. Believe it or not, a certain number of surgeons that remove prostate glands do this as a business to make money but careless about your health. 7. After the surgery, you will never know if your prostate was or was not really cancerous. Why? Because the gland is sent to the laboratory to determine that. But if the results are negative, it is too late. The system is rigged. 8. Even if you have prostate cancer, you need to get three (3) opinions as to the procedure. Don't settle for less. 9. Interview both urologist and the surgeon if all three (3) opinions are confirming you have prostate cancer. 10. It is your body and your prostate, read this book before making a drastic decision.




3rd Opinion on Prostate Cancer


Book Description

The minute that your urologist tells you that your biopsy is positive for prostate cancer, don't panic. I have been there and that is why this book is written. Here are ten facts: 1. Identifying cancerous cells in a biopsy of prostate gland is more difficult than identifying any other cancerous cells in biopsies of any other organs. 2. Laboratories often make mistakes, especially the laboratory that determined I had prostate cancer when I really did not. 3. Elevated PSA and MRI scanning is not accurate to determine prostate cancer, especially if you have an infection that elevates PSA. 4. If you ask your physician that you need to get a second opinion, s/he would refer you to urologists in his/her circle, locally. More than likely, the second opinion will confirm the first opinion of the primary physician. 5. In any surgery, especially prostate cancer surgery, you need to get additional two opinions, and the third one must be out of the state that you reside. 6. Believe it or not, a certain number of surgeons that remove prostate glands do this as a business to make money but careless about your health. 7. After the surgery, you will never know if your prostate was or was not really cancerous. Why? Because the gland is sent to the laboratory to determine that. But if the results are negative, it is too late. The system is rigged. 8. Even if you have prostate cancer, you need to get three (3) opinions as to the procedure. Don't settle for less. 9. Interview both urologist and the surgeon if all three (3) opinions are confirming you have prostate cancer. 10. It is your body and your prostate, read this book before making a drastic decision.




The Prostate Cancer Primer


Book Description

The impact of advances in medical technologies is beginning to reveal that Prostate Cancer is a much larger problem than the general public perceives. Newer tools for diagnosing tiny microscopic cancer cells in younger men have caused the medical community to recommend that men in their early 40's get a PSA Cancer screen with routine physical exams, instead of waiting until they are in their late 50's, only then to discover cancer is present. The medical community is not doing a good job of communicating that we may be heading for a pandemic if diagnosis and treatment is not routinely conducted in younger and younger men. The Prostate Cancer Primer is the culmination of a research professor's intense effort to: *learn about current options that are available for preventing cancer; *suggestions for understanding what currently available treatment options their are, complete with side-effects; *how to choose which treatment is right for today's health-conscious adult man and his family. Oncologists and urologists interviewed for this Primer are in basic agreement that too little communication exists between the medical community and men who need to know what their prostate options are. This compilation of research is aimed at filling that void, for all men who are interested in living a healthful life.




Prostate Cancer: a Family Affair


Book Description

This book was written to share my family members' experiences with prostate cancer. We have had three generations of prostate cancer in our family. My primary purpose is to describe what the last two generations did to increase our chances for longevity post-surgery. I was diagnosed in 1994 at age 59. My brother Carl was diagnosed in 2005 at age 67. My son was diagnosed in 2016 at age 53. We are survivors. Learn how we dealt with many challenges men face with prostate cancer. Also, learn the importance of a spouse, family, and friends during these difficult stages in our lives. In this book, we share:1.Important steps we took to improve prostate cancer survivability.2.What questions to ask your doctor.3.Which treatment option may give you a longer and better quality-of-life.4.Importance of follow-up test after prostate cancer treatment to stay ahead of cancer trying to return.5.How our family members experienced Prostate Cancer Having prostate cancer is a life-changing event. How you deal with your diagnosis and treatment to maximize long-term survivability is the most important thing. Sure, there were many things we had to learn in order to improve the quality of lives and deal with these problems.We each underwent one of three different prostate cancer procedures and treatments. Each of us had a different outcome, but we are all still alive to enjoy our lives. This book is for information and inspiration only. It is not intended to be medical advice. I am not a physician, and I have never worked in the medical field.I dedicate this book to the memories of all men and their loved ones who have lost their fight to prostate cancer.




Proton Warriors


Book Description

If you (or a loved one) have recently been diagnosed with prostate cancer, danger lies ahead. Efforts will be made to either treat it unnecessarily or with procedures with risks of side effects so severe you will regret it. The Prostate Cancer Industry is a vast array of medical device manufacturers, heath care facilities, physicians and others who generate over a billion dollars annually from treating prostate cancer of which only 20% is actually life threatening. Efforts will be made to scare you into believing you need immediate treatment with most of you being encouraged to have surgery or other treatment provided by the urologist who diagnosed your prostate cancer or an associate. DON'T RUSH INTO TREATMENT until you have obtained an independent second or third opinion from a medical oncologist or internist unrelated to the physician who diagnosed it. To survive prostate cancer AND the prostate cancer industry you must educate yourself on prostate cancer and the different ways it can be treated. Keep in mind that what is in your doctor's best interest may not always be in your best interest. The author selected the non-invasive treatment of proton therapy because of its established effectiveness and least risk of serious side effects. He describes his surprisingly pleasant journey through prostate treatment and encourages you to consider proton therapy as your treatment.




Management of Prostate Cancer


Book Description

Although much progress has been made in the four years since the first edition of Management of Prostate Cancer, prostate cancer remains a significant biological, me- cal, and personal challenge for millions of men. In this interval, some important trends and observations have emerged that represent real progress in the field and which will shape the direction of clinical practice and research in the next 5–10 years. These obs- vations include: (1) a decline in prostate-related cancer mortality in the United States, likely owing to a combination of factors including screening, more aggressive and earlier therapy, and improvements in specific therapies; (2) a significant downward pathological stage migration, so that an individual’s chance of cure for a given stage, grade, and PSA is better now than it was early in the PSA era, even without associated improvements in individual therapies; (3) the recognition of new PSA isoforms that may refine screening strategies; (4) several randomized, phase III clinical trials demonstrating survival adv- tages of one form of therapy over another in selected populations (external beam rad- therapy with adjuvant hormones vs radiotherapy alone, radical prostatectomy vs observation); (5) a focus on the biology of bone and bone metastasis, and new agents that reduce skeletal-related events and which may inhibit the growth of new metastases; (6) second-generation anti-PSMA antibodies with improved potential for imaging and therapy; (7) the development and widespread adoption of nomograms that assist in cli- cal decision-making for individual patients; (8) the identification of new genes that




Dr. Patrick Walsh's Guide to Surviving Prostate Cancer


Book Description

This guide covers every aspect of prostate cancer, from potential causes including diet to tests for diagnosis, curative treatment, and innovative means of controlling advanced stages of cancer.




Prostate Cancer: A Comprehensive Perspective


Book Description

Prostate cancer is the commonest male cancer with over 5 million survivors in US alone. Worldwide, the problem is staggering and has attracted significant attention by media, scientists and cancer experts. Significant research, discoveries, innovations and advances in treatment of this cancer have produced voluminous literature which is difficult to synthesize and assimilate by the medical community. Prostate Cancer: A Comprehensive Perspective is a comprehensive and definitive source which neatly resolves this problem. It covers relevant literature by leading experts in basic science, molecular biology, epidemiology, cancer prevention, cellular imaging, staging, treatment, targeted therapeutics and innovative technologies. Prostate Cancer: A Comprehensive Perspective, is a valuable and timely resource for urologists and oncologists.




Prostate Cancer


Book Description

The purpose of this book is to provide a contemporary overview of the causes and consequences of prostate cancer from a cellular and genetic perspective. Written by experts in the fields of epidemiology, toxicology, cell biology, genetics, genomics, cell-cell interactions, cell signaling, hormone signaling, and transcriptional regulation, the text covers aspects of prostate cancer from disease initiation to metastasis. Chapters explore in depth the cells of origin for prostate cancer, its genomic subtypes, neural transcription factors in disease progression, epigenetic regulation of chromatin, and many other topics. This book distinguishes itself from other texts on prostate cancer by its focus on cellular and genetic mechanisms, as opposed to clinical diagnosis and management. As a result, this book will be of broad interest to basic and translational scientists with familiarity of these topics, as well as to trainees at earlier stages of their research careers.